<?xml version="1.0" encoding="UTF-8"?>
<ref id="B36-viruses-12-01039">
 <label>36.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Catanzaro</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Fagiani</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Racchi</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Corsini</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Govoni</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lanni</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Immune response in COVID-19: Addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2</article-title>
  <source>Signal Transduct. Target. Ther.</source>
  <year>2020</year>
  <volume>5</volume>
  <fpage>84</fpage>
  <pub-id pub-id-type="doi">10.1038/s41392-020-0191-1</pub-id>
  <pub-id pub-id-type="pmid">32467561</pub-id>
 </element-citation>
</ref>
